Generation Of Tumor-Reactive T Cells
Source: Miltenyi Biotec

Uncover fully automated stimulation, labelling, enrichment, activation, transduction, and expansion of human T cells from patient material (either derived from tumor or via leukapheresis) for the production of tumor-reactive T cells. Here, we present an overview of the specifications and materials required to perform the Tumor Reactive T Cell (TRT) Process on the CliniMACS Prodigy. In addition, we illustrate the process workflow and tubing set configuration and provide performance data of in-house results.
access the Datasheet!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Miltenyi Biotec
This website uses cookies to ensure you get the best experience on our website. Learn more